Financing channel feed – Endpoints News

Financing channel feed

Medicxi, RA Capital join $30M round for Dutch biotech's late-stage transplantation med

7 years ago

Polyphor parlays a pathogen-specific antibiotic and I/O work into a $165M IPO for its PhIII program

7 years ago

Third Rock, GV back Broad spinout Celsius in bid to develop precision meds for autoimmune disease

7 years ago

Cambridge spinout CellCentric gets $26M for single-asset epigenetics approach to prostate cancer

8 years ago

Waksal's gene therapy spinoff MeiraGTx says it’s time to fly with an $86M IPO

8 years ago

Targeting the tricky PI3K pathway in cancer, MEI gets $75M to push program through registration study

8 years ago

CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing tech

8 years ago

China's CStone bags $260M Series B for ambitious I/O work, expanding its list of marquee investors

8 years ago

Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback

8 years ago

Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A

8 years ago

Temasek, corporate VCs buy into prescription digital med hopes in Akili's $55M Series C

8 years ago

Evelo Bio grabs $85M as the latest early-stage biotech debuts on Nasdaq

8 years ago

Listing in Shanghai, WuXi AppTec raises a $354M IPO for China R&D facilities

8 years ago

Autolus engineers a $100M-plus IPO for itself as it blueprints a new generation of better, safer cell therapies

8 years ago

Set to be the first pre-revenue biotech to list in Hong Kong, Ascletis lays out priorities in IPO application

8 years ago

Splat: Singapore's Aslan tanks on Nasdaq debut, raising $42M in IPO and trending down

8 years ago

Raising a record $668M in new fund, Foresite sets sights on a tech-driven portfolio

8 years ago

Third Rock sinks $59M into Casma's 'recycling' tech, with neuro on the mind

8 years ago

Iterum tests public market's appetite for anti-infectives in $92M IPO

8 years ago

Chinese investors back Refuge Bio’s $25M B round as it steers gene engineering tech to an IND

8 years ago

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers

8 years ago

Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year

8 years ago

IL-2 without the toxic side effects? Orbimed backs the idea in Synthorx' $63M round

8 years ago

What do you get when you integrate healthcare data from multiple sources into one comprehensive, global package? Travis May says he’s on track to find out

8 years ago

First page Previous page 127 128 129130131 132 133 Next page Last page